Cannabis

Search documents
MJ: Midterms Could Offer Investors Chance To Enjoy High Returns With Cannabis Stocks
Seeking Alpha· 2025-10-01 18:19
Despite Republican efforts to block rescheduling, I believe President Trump will leverage cannabis and rescheduling to shore up support during the midterm elections, which should boost Amplify Alternative Harvest ETF (NYSEARCA:Markets rise and fall, booms come and go, and the world keeps ticking. Ultimately, I believe observing megatrends, as difficult as they can be to spot, let alone fully comprehend, can yield insights into the advance of human society, which in turn could pave the way for many useful in ...
3 Best Marijuana Stocks to Buy in October
The Motley Fool· 2025-10-01 13:00
These three cannabis companies offer different ways to play an industry that's down by 80% from its peak, but showing signs of life.The cannabis sector remains one of the most challenging areas to invest in successfully. The space is volatile, highly regulated, and filled with companies that have yet to demonstrate that they can produce long-term profitability. At the same time, the potential for policy changes, endorsements of cannabis for medical or wellness uses, and renewed investor interest keep the in ...
3 Best Cannabis Penny Stocks to Watch as U.S. Legalization Momentum Builds
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-09-23 14:00
Top Marijuana Penny Stocks to Watch This Week Amid Industry GrowthThe U.S. cannabis industry continues to expand despite recent market volatility. In 2024, legal cannabis sales surpassed $30 billion nationwide. Analysts project sales could grow to nearly $50 billion by 2030. This growth is fueled by the opening and expansion of new markets and medical programs. Recently, headlines focused on ongoing discussions about federal legalization and potential reclassification of cannabis under the Controlled Substa ...
High Tide (HITI) - 2025 Q3 - Earnings Call Transcript
2025-09-16 16:32
Financial Data and Key Metrics Changes - Revenue for Q3 reached an all-time high of $149.7 million, up 14% year over year and 9% sequentially [22] - Adjusted EBITDA was a record $10.6 million, up 11% year over year and 32% sequentially [24] - Free cash flow of $7.7 million grew 148% year over year, marking the second highest level since disclosure began [9][26] - Net income turned positive at $832,000, a significant turnaround from a $2.8 million net loss in Q2 [9] Business Line Data and Key Metrics Changes - Bricks-and-mortar revenue was a record, up 18% year over year, with same-store sales growth accelerating to 7.4% [7][22] - Bricks-and-mortar adjusted EBITDA reached an all-time high of $12.7 million, up 42% year over year [9][24] - E-commerce business continues to underperform, with less than 3% of consolidated revenues, prompting management to implement changes [25][47] Market Data and Key Metrics Changes - Canna Cabana's market share across five operating provinces reached 12%, the highest since legalization [8] - In Germany, the company started with a 16% market share, leveraging relationships with licensed producers [13][19] Company Strategy and Development Direction - The company aims to expand its brick-and-mortar presence, targeting 300 stores in Canada, with plans to open 20 to 30 new locations annually [40] - The recent acquisition of Remexian is seen as a strategic move to enter the German market, with plans to leverage existing relationships with Canadian licensed producers [10][11] - The company is focused on curating a diverse menu of cannabis strains in Germany and expanding into other European markets [15][63] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued strength of the bricks-and-mortar business, with no signs of slowing down in same-store sales [8][31] - The company is optimistic about the integration of Remexian and the potential for growth in the German market, despite temporary supply chain issues from Portugal [39][41] - Management highlighted the importance of maintaining a strong balance sheet while pursuing growth opportunities [18][39] Other Important Information - The company has closed a $30 million junior subordinated loan with Kronos, which is seen as validation of its strategy [18] - Management emphasized the importance of operational efficiency, with salaries and wages representing 12.2% of revenue, the lowest in seven quarters [24] Q&A Session Summary Question: How much of the recent acceleration in same-store sales is due to industry improvement versus market share gains? - Management indicated that the company has the best retail model, contributing to the acceleration in same-store sales, with competitor closures playing a minor role [30][31] Question: What is the company's philosophy on capital allocation post-Remexian transaction? - Management stated that significant working capital is required for growth, and they plan to use raised funds to support Remexian while continuing organic store openings [38][39] Question: How confident is the company in executing a turnaround for the e-commerce business? - Management acknowledged the underperformance of the e-commerce segment but expressed optimism about new initiatives and partnerships to improve sales [47][49] Question: What is driving the expansion of margins in the bricks-and-mortar segment? - Management attributed margin expansion to a combination of white label sales, price increases, and operational efficiencies [54] Question: How are newer stores performing relative to prior cycles? - Management reported that newer stores are ramping up sales faster than expected, benefiting from the strong brand recognition of Canna Cabana [58][60] Question: What are the opportunities for expansion in other European markets? - Management indicated that while the focus is on integrating Remexian, they are monitoring other EU markets for potential entry when compelling opportunities arise [63]
High Tide (HITI) - 2025 Q3 - Earnings Call Transcript
2025-09-16 16:32
High Tide (NasdaqCM:HITI) Q3 2025 Earnings Call September 16, 2025 11:30 AM ET Company ParticipantsMayank Mahajan - CFOFrederico Gomes - Director, Institutional Research, Life SciencesRaj Grover - President, CEOCarter Brownlee - Advisor, Communications and Public AffairsBill Kirk - Managing DirectorConference Call ParticipantsMichael Kim - Senior AnalystAndrew Semple - Equity Research AnalystNeil Gomer - AnalystOperatorGood morning. My name is Jenny, and I will be your conference operator today. At this tim ...
SNDL Releases Second Quarter 2025 Financial and Operational Results
Yahoo Finance· 2025-09-16 14:27
Group 1 - SNDL Inc. reported Q2 2025 net sales of $244.8 million, a 7.3% year-over-year increase, driven by a 17.4% growth in its cannabis business and a recovery in its liquor retail division [1] - The company achieved an operating income of $5.0 million, with a gross profit of $67.6 million, reflecting a 16.2% increase and a gross margin of 27.6% [1] - SNDL Inc. had no debt and $208.2 million in unrestricted cash at the end of the quarter, despite a negative free cash flow of $7.9 million due to working capital investments and CAPEX [1] Group 2 - CEO Zach George highlighted that Q2 marked the first positive operating income and net earnings for SNDL Inc. [2] - Strategic initiatives included a $32.2 million agreement to acquire 32 cannabis outlets, the launch of the Rise Rewards loyalty program, and a $9.5 million CAPEX investment for retail expansion [2] - The company has increased exports to the UK and EU while developing its U.S. strategy, positioning itself as one of the best marijuana stocks [2]
X @The Wall Street Journal
The Wall Street Journal· 2025-09-13 10:50
More women are using cannabis during pregnancy, driven by fears about prescription drugs and beliefs it’s safe for conditions like nausea. Data on the effects on a fetus are sparse. https://t.co/XYXmiazf5r ...
2 Marijuana Stocks For Cannabis Investors Looking To Make A Profit
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-09-06 13:10
Industry Overview - The global cannabis industry has made significant progress, with countries like Canada leading in full legalization, which is expected to influence the U.S. and Europe positively [1] - The movement towards legal cannabis has been a collective effort, with smaller players playing a crucial role in shaping the industry [2] Legislative Impact - Ongoing voting on laws aims to support both smaller operators and larger companies in the cannabis market, emphasizing the importance of community involvement in legitimizing cannabis as a product [3] Company Highlights Jushi Holdings Inc. - Jushi Holdings reported total revenue of $65.0 million for Q2 2025, with a gross profit of $28.9 million and a gross profit margin of 44.5% [7] - The company experienced a net loss of $12.3 million and an adjusted EBITDA of $13.7 million, reflecting a margin of 21.1% [7] - Cash and cash equivalents stood at $25.2 million at the end of the quarter [7] Planet 13 Holdings Inc. - Planet 13 reported revenue of $26.9 million for Q2 2025, a decrease of 13.6% from $31.1 million [11] - The gross profit was $11.7 million, with a gross profit margin of 43.4%, down from 50.9% [11] - The company faced a net loss of $13.3 million, compared to a net loss of $8.1 million in the previous period [11]